|
[Related PubMed/MEDLINE]
Total Number of Papers: 15408
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: ER |
| Long Form |
: estrogen receptor |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2021 |
Correlation between numerical and categorical immunohistochemical score of Ki-67 and HER2 with clinicopathological parameters of breast cancer. |
BC, HER2, PR |
| 2 |
2020 |
4-Hexylphenol influences adipogenic differentiation and hepatic lipid accumulation invitro. |
4-HP, EDC, OA, PPARgamma |
| 3 |
2020 |
6'-Methoxy Raloxifene-analog enhances mouse bone properties with reduced estrogen receptor binding. |
OI, RAL, RAL-A, SERM, WT |
| 4 |
2020 |
90 YEARS OF PROGESTERONE: Progesterone and progesterone receptors in breast cancer: past, present, future. |
PR |
| 5 |
2020 |
90 YEARS OF PROGESTERONE: Progesterone receptor signaling in the normal breast and its implications for cancer. |
BM, ECM, PR |
| 6 |
2020 |
A 3D Heterotypic Breast Cancer Model Demonstrates a Role for Mesenchymal Stem Cells in Driving a Proliferative and Invasive Phenotype. |
BC, BCCs, EMT, MSAB, MSCs, PR, SnON, TGF-beta |
| 7 |
2020 |
A Case of Carcinosarcoma of the Breast Presenting as Inflammatory Carcinoma and Review of the Literature. |
PR, SMA |
| 8 |
2020 |
A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese women. |
BC, NTUH, OR, PFAS, PFOS |
| 9 |
2020 |
A comparative study of the value of amide proton transfer-weighted imaging and diffusion kurtosis imaging in the diagnosis and evaluation of breast cancer. |
APTWI, DKI, HER2, Kapp, PR |
| 10 |
2020 |
A deletion mutation within the ATBF1 gene is strongly associated with goat litter size. |
SWCG |
| 11 |
2020 |
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis. |
--- |
| 12 |
2020 |
A novel and cost-effective ex vivo orthotopic model for the study of human breast cancer in mouse mammary gland organ culture. |
BCa-MMOC, EGFR, MMOC, PR |
| 13 |
2020 |
A novel GPER antagonist protects against the formation of estrogen-induced cholesterol gallstones in female mice. |
CIMBA, GPER |
| 14 |
2020 |
A novel tumor suppressor ZBTB1 regulates tamoxifen resistance and aerobic glycolysis through suppressing HER2 expression in breast cancer. |
ERalpha, miRNAs, ZBTB1 |
| 15 |
2020 |
A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions using 18F-FES PET/CT imaging. |
ABC, CBR, ORR, RECIST |
| 16 |
2020 |
A polycyclic aromatic hydrocarbon-enriched environmental chemical mixture enhances AhR, antiapoptotic signaling and a proliferative phenotype in breast cancer cells. |
AhR, EDCs, PAH |
| 17 |
2020 |
A population-based analysis of breast cancer incidence and survival by subtype in Ontario women. |
BCa, mOS, PgR, TNBC |
| 18 |
2020 |
A preclinical PET dual-tracer imaging protocol for ER and HER2 phenotyping in breast cancer xenografts. |
4FMFES, HER2, p.i, ROI |
| 19 |
2020 |
A prognostic eight-lncRNA expression signature in predicting recurrence of ER-positive breast cancer receiving endocrine therapy. |
lncRNAs |
| 20 |
2020 |
A Qualitative Transcriptional Signature for Predicting Extreme Resistance of ER-Negative Breast Cancer to Paclitaxel, Doxorubicin, and Cyclophosphamide Neoadjuvant Chemotherapy. |
DRFS, NAC, pCR, RD, REO |
| 21 |
2020 |
A Randomized, Open-label, Presurgical, Window-of-Opportunity Study Comparing the Pharmacodynamic Effects of the Novel Oral SERD AZD9496 with Fulvestrant in Patients with Newly Diagnosed ER+ HER2- Primary Breast Cancer. |
PR |
| 22 |
2020 |
A rapid volume of interest-based approach of radiomics analysis of breast MRI for tumor decoding and phenotyping of breast cancer. |
PR, VOI |
| 23 |
2020 |
A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer. |
BC, EGFR, HER2, NLCs, PR, SLNs, TNBC, VEGF |
| 24 |
2020 |
Abilities of beta-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells. |
PDAC |
| 25 |
2020 |
Absence of estrogen receptor is associated with worse oncologic outcome in patients who were received neoadjuvant chemotherapy for breast cancer. |
IHC, NAC, PR |
| 26 |
2020 |
Accelerated Tissue Processing With Minimal Formalin Fixation Time for 9-Gauge Vacuum-Assisted Breast Biopsy Specimens. |
HER2, PR, VAB |
| 27 |
2020 |
Accurate assessment of estrogen receptor profiles in non-functioning pituitary adenomas using RT-digital PCR and immunohistochemistry. |
NFPAs, RT-dPCR |
| 28 |
2020 |
Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast Cancer. |
--- |
| 29 |
2020 |
Adiposity and estrogen receptor-positive, postmenopausal breast cancer risk: Quantification of the mediating effects of fasting insulin and free estradiol. |
BMI, CI, IDE, IIE, RR |
| 30 |
2020 |
Adjuvant endocrine treatment for estrogen receptor (ER)-positive/HER2-negative breast cancer. |
CI, HR, OFS, RR, SOFT, TEXT |
| 31 |
2020 |
Adjuvant radiation therapy alone is associated with improved overall survival compared to hormonal therapy alone in older women with estrogen receptor positive early stage breast cancer. |
BCS, HR, HT, NCDB, OS, RT |
| 32 |
2020 |
Advances in the Molecular Taxonomy of Breast Cancer. |
HER2 |
| 33 |
2020 |
Advantages in Wound Healing Process in Female Mice Require Upregulation A2A-Mediated Angiogenesis under the Stimulation of 17beta-Estradiol. |
WT |
| 34 |
2020 |
Age, Sex, and Depot-Specific Differences in Adipose-Tissue Estrogen Receptors in Individuals with Obesity. |
AT, OM |
| 35 |
2020 |
AGR3 promotes estrogen receptor-positive breast cancer cell proliferation in an estrogen-dependent manner. |
AGR3, ESR1, si |
| 36 |
2020 |
All-cause and cardiovascular disease mortality among breast cancer survivors in CLUE II, a long-standing community-based cohort. |
CIs, CVD, HRs |
| 37 |
2020 |
Allergy, asthma, and the risk of breast and prostate cancer: a Mendelian randomization study. |
CIs, ORs |
| 38 |
2020 |
Alternaria toxins as casein kinase 2 inhibitors and possible consequences for estrogenicity: a hybrid in silico/in vitro study. |
ATX-II, CK2 |
| 39 |
2020 |
Amphiregulin mediates the hormonal regulation on Rspondin-1 expression in the mammary gland. |
AREG, Rspo1 |
| 40 |
2020 |
Amphiregulin retains ERalpha expression in acquired aromatase inhibitor resistant breast cancer cells. |
AIs, AREG, EGFR, FOXM1, SGK3 |
| 41 |
2020 |
AMPK Activation by Metformin Promotes Survival of Dormant ER+ Breast Cancer Cells. |
AMPK |
| 42 |
2020 |
An interesting case of likely BRCA2 related bilateral breast cancer with metastasis in the fimbrial part of fallopian tube. |
PgR |
| 43 |
2020 |
An investigation of the relationship between TMPRSS6 gene expression, genetic variants and clinical findings in breast cancer. |
MCHC, TMPRSS6 |
| 44 |
2020 |
Analysis of H3K4me3 and H3K27me3 bivalent promotors in HER2+ breast cancer cell lines reveals variations depending on estrogen receptor status and significantly correlates with gene expression. |
--- |
| 45 |
2020 |
Analysis of the molecular subtypes of preoperative core needle biopsy and surgical specimens in invasive breast cancer. |
CNB, CR, HER2, PR |
| 46 |
2020 |
Androgen signaling pathways driving reproductive and metabolic phenotypes in a PCOS mouse model. |
AR, ARKO, DHT, PCOS |
| 47 |
2020 |
Anti-cell growth and anti-cancer stem cell activity of the CDK4/6 inhibitor palbociclib in breast cancer cells. |
CDK, CSC, HER |
| 48 |
2020 |
Anticancer Melatplatin Prodrugs: High Effect and Low Toxicity, MT1-ER-Target and Immune Response In Vivo. |
MT |
| 49 |
2020 |
APOBEC3B expression in breast cancer cell lines and tumors depends on the estrogen receptor status. |
A3A, A3B |
| 50 |
2020 |
Aquaporin expression in breast cancer and their involvement in bleb formation, cell motility and invasion in endocrine resistant variant cells. |
AQPs, siRNA |
| 51 |
2020 |
Arctigenin inhibits proliferation of ER-positive breast cancer cells through cell cycle arrest mediated by GSK3-dependent cyclin D1 degradation. |
Arc |
| 52 |
2020 |
ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response. |
CRISPR |
| 53 |
2020 |
ARID1A-dependent permissive chromatin accessibility licenses estrogen-receptor signaling to regulate circadian rhythms genes in endometrial cancer. |
--- |
| 54 |
2020 |
Aromatase inhibitor therapy in recurrent, estrogen-receptor positive uterine serous carcinoma: A case report. |
USC |
| 55 |
2020 |
Aromatase Inhibitors as Adjuvant Treatment for ER/PgR Positive Stage I Endometrial Carcinoma: A Retrospective Cohort Study. |
AIs, EC, OS, PFS, PgR |
| 56 |
2020 |
Assessing species-specific differences for nuclear receptor activation for environmental water extracts. |
AR, EDCs, GR, MR, PPARgamma, PR, PXR |
| 57 |
2020 |
Assessing the Burden of Nodal Disease for Breast Cancer Patients with Clinically Positive Nodes: Hope for More Limited Axillary Surgery. |
ALND, NAC |
| 58 |
2020 |
Assessment of Anti-Mullerian Hormone and Anti-Mullerian Hormone Type II Receptor Variants in Women with Repeated Implantation Failures. |
AMH, AMHRII, IGFBP-1, PRL, RIF |
| 59 |
2020 |
Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium. |
BCAC, OR, SNP |
| 60 |
2020 |
Assessment of the Predictive Role of Serum Lipid Profiles in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. |
HDL-C, LDL-C, NAC, TC, TG |
| 61 |
2020 |
Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer. |
HR, LRR, PR |
| 62 |
2020 |
Association between gastrin-releasing peptide receptor expression as assessed with [68Ga]Ga-RM2 PET/CT and histopathological tumor regression after neoadjuvant chemotherapy in primary breast cancer. |
BC, NAC, PET |
| 63 |
2020 |
Association between low estrogen receptor positive breast cancer and staining performance. |
TMA |
| 64 |
2020 |
Association of circulating Progesterone Receptor Membrane Component-1 (PGRMC1) with breast tumor characteristics and comparison with known tumor markers. |
AUC, CEA, PGRMC1, PR, ROC |
| 65 |
2020 |
Association of genetic variants in Estrogen receptor (ESR)1 and ESR2 with susceptibility to recurrent pregnancy loss in Tunisian women: A case control study. |
BMI, ESR, ESR, MAF, RPL |
| 66 |
2020 |
Association of Independent Prognostic Factors and Treatment Modality With Survival and Recurrence Outcomes in Breast Cancer. |
aHR, OS, RFS |
| 67 |
2020 |
Association of Insulin, Metformin, and Statin with Mortality in Breast Cancer Patients. |
HR |
| 68 |
2020 |
Association of the Implant Surface Texture Used in Reconstruction With Breast Cancer Recurrence. |
BIA-ALCL, DFS, HRs, LRRFS |
| 69 |
2020 |
Association of triple positivity with prognostic parameters and overall survival in a population-based study of 6,122 HER2-positive breast cancer patients: analysis of real-world clinical practice based on a research database. |
HR, OS, PR, TPBC |
| 70 |
2020 |
Basal-like Breast Cancer: Comparison of Imaging Characteristics. |
HER2, ICMF, PR |
| 71 |
2020 |
Benzo[a]pyrene exposure induced reproductive endocrine-disrupting effects via the steroidogenic pathway and estrogen signaling pathway in female scallop Chlamys farreri. |
ADCY, Cav-1, PKA, VTG |
| 72 |
2020 |
Bicalutamide plus Aromatase Inhibitor in Patients with Estrogen Receptor-Positive/Androgen Receptor-Positive Advanced Breast Cancer. |
AI, AR, CBR, ORR, PFS |
| 73 |
2020 |
BIK drives an aggressive breast cancer phenotype through sublethal apoptosis and predicts poor prognosis of ER-positive breast cancer. |
BIK |
| 74 |
2020 |
Binding Assays Using a Benzofurazan-Labeled Fluorescent Probe for Estrogen Receptor-Ligand Interactions. |
hr-ERalpha |
| 75 |
2020 |
Binding specificities of estrogen receptor with perfluorinated compounds: A cross species comparison. |
PFCs |
| 76 |
2020 |
Bioassay guided analysis coupled with non-target chemical screening in polyethylene plastic shopping bag fragments after exposure to simulated gastric juice of Fish. |
NTS |
| 77 |
2020 |
Bioinformatic analysis of the expression and prognostic value of chromobox family proteins in human breast cancer. |
CBX, NPI, PR, SBR |
| 78 |
2020 |
Bioinformatics Analysis of Metabolomics Data Unveils Association of Metabolic Signatures with Methylation in Breast Cancer. |
BC, pam, PAM, SAM |
| 79 |
2020 |
Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer. |
bc-GenExMiner, DFS, DMFS, HER2, LRRC15, OS, PR, RFS, SBR |
| 80 |
2020 |
Bioinformatics analysis of prognostic value of PITX1 gene in breast cancer. |
NOD2, NPI, PR, SBR |
| 81 |
2020 |
Biological effects of chronic and acute exposure of human endothelial cell line EA.hy926 to bisphenol A: New tricks from an old dog. |
BPA, EC, eNOS, NO, ZO-1 |
| 82 |
2020 |
Biomarker heterogeneity between primary breast cancer and synchronous axillary lymph node metastases. |
ALN, ASCO, BC, CAP, HER2, PR |
| 83 |
2020 |
Biomarker Modulation Study of Celecoxib for Chemoprevention in Women at Increased Risk for Breast Cancer: A Phase II Pilot Study. |
IGF-1, IGFBP-1 |
| 84 |
2020 |
Biomarker phenotyping drives clinical management in axillary sentinel node: A retrospective study on women with primary breast cancer in 2002. |
ALND, PgR, SLNB |
| 85 |
2020 |
Biomarkers of neoadjuvant/adjuvant endocrine therapy for ER-positive/HER2-negative breast cancer. |
--- |
| 86 |
2020 |
Biomimetic and estrogenic fibers promote tissue repair in mice and human skin via estrogen receptor beta. |
HA, SPI |
| 87 |
2020 |
Bispecific Antibodies for Triple Negative Breast Cancer. |
HER2, TNBC |
| 88 |
2020 |
Bisphenol a Exposure in Utero Disrupts Hypothalamic Gene Expression Particularly Genes Suspected in Autism Spectrum Disorders and Neuron and Hormone Signaling. |
BNST, BPA, DEGs, MPOA |
| 89 |
2020 |
Bisphenol A-induced oxidative stress, hepatotoxicity and altered estrogen receptor expression in Labeo bata: impact on metabolic homeostasis and inflammatory response. |
BPA, NO, VTG |
| 90 |
2020 |
Bleeding risk in breast cancer patients during concomitant administration of warfarin and tamoxifen: A population-based nested case-control study. |
CI, OR |
| 91 |
2020 |
Blocking of Estradiol Receptors ERalpha, ERbeta and GPER During Development, Differentially Alters Energy Metabolism in Male and Female Rats. |
--- |
| 92 |
2020 |
BMI, physical activity, and breast cancer subtype in white, black, and Sea Island breast cancer survivors. |
AA, BC, EA, PA, SI |
| 93 |
2020 |
Borderline Estrogen Receptor-Positive Breast Cancers in Black and White Women. |
CI, DFI, HR, RFD |
| 94 |
2020 |
BRAF/MEK Pathway is Associated With Breast Cancer in ER-dependent Mode and Improves ER Status-based Cancer Recurrence Prediction. |
HR |
| 95 |
2020 |
BRCA Detection Rate in an Italian Cohort of Luminal Early-Onset and Triple-Negative Breast Cancer Patients without Family History: When Biology Overcomes Genealogy. |
BC, TNBC |
| 96 |
2020 |
BRCA Mutational Status is a Promising Predictive Biomarker for Platinum-based Chemotherapy in Triple-Negative Breast Cancer. |
BRCA, HER2, HRR, PARPi, Rp, TNBC |
| 97 |
2020 |
Breast cancer in Andaman and Nicobar Islands: A retrospective analysis. |
PR |
| 98 |
2020 |
Breast Cancer in Men: A Single Center Experience Over a Period of 22 years. |
MBC, PR |
| 99 |
2020 |
Breast cancer organoids from a patient with giant papillary carcinoma as a high-fidelity model. |
PR |
| 100 |
2020 |
Breast cancer pathogenesis is linked to the intra-tumoral estrogen sulfotransferase (hSULT1E1) expressions regulated by cellular redox dependent Nrf-2/NFkappabeta interplay. |
Nrf2 |
|
A Search Service for Abbreviation / Long Form
